Budget Impact Analysis of Sunitinib Versus Best Supportive Care for The Treatment of Metastatic Renal Cell Carcinoma in Chile (Englisch)

in VALUE IN HEALTH ; 19 , 7 ; A718-
VALUE IN HEALTH
Wie erhalte ich diesen Titel?
TIB vor Ort

Für Benutzerinnen und Benutzer auf dem LUH Campus überprüfen wir gerne den kostenfreien Bezug.

Anfrage Verfügbarkeit LUH

Dokumentinformationen

  • Titel:
    Budget Impact Analysis of Sunitinib Versus Best Supportive Care for The Treatment of Metastatic Renal Cell Carcinoma in Chile
  • Autor / Urheber:
  • Zeitschrift / Reihe:
  • Band:
    19
  • Ausgabe:
    7
  • Seite:
    A718-
  • Verlag:
    Elsevier Science B.V., Amsterdam
  • Erscheinungsjahr:
    2016
  • Format / Umfang:
    A718-
  • ISSN:
  • Medientyp:
    Aufsatz (Zeitschrift)
  • Format:
    Print
  • Sprache:
    Englisch
  • Klassifikation:
    DDC:    610

Inhaltsverzeichnis – Band 19, Ausgabe 7

Zeige alle Jahrgänge und Ausgaben

Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Nachweisen der enthaltenen Aufsätze. Die Anzeige der Jahrgänge kann aufgrund fehlender Aufsatznachweise unvollständig oder lückenhaft sein, obwohl die Zeitschrift komplett in der TIB verfügbar ist.

A347
The Impact of Dynamic Transmission Modelling on the Estimated Cost-Effectiveness of Treatment for Chronic Hepatitis C in The United Kingdom
Madin-Warburton, M. / Pitcher, A. / Martin, N. | 2016
A347
The Impact of Extrapolating Survival Based on Cure Models: Comparing Mean Incremental Survival and Cure Rates in Different Datasets
van Oostrum, I. / Postma, M. / Buskens, E. / Heeg, B. | 2016
A347
Aligned and Flexible? A Comparative Review of SMC and Nice Decision-Making
Johnson, H / Spoors, J / Johnson, J | 2016
A347
Considering or Not Adverse Events in Health Economic Models: A Pragmatic Approach
Roze, S. / Cartier-Bechu, C. / Gherardi, A. / Monnier, R. / Pignata, M. / Petijean, A. / Sivignon, M. | 2016
A347
Achieving Optimal Fit-To-Survival Data Using Cubic Spline Models: A Case-Study Comparing The Fit of Standard and Cubic Spline Models to Survival Data from the Icon6 Study
Hettle, R. / Sackeyfio, A. / Suri, G. | 2016
A348
Actuarial Approaches To Modelling and Mitigating Financial Uncertainty in Recommending New Drugs and Health Technologies
Buckle, J. / Serre, D. | 2016
A348
Implementation of Conditional Reimbursement Schemes in HTA Practice: Experiences from the Netherlands
Makady, A. / Nijmeijer, H. / de Boer, A. / Hillege, J. / Klungel, O. / Goettsch, W. | 2016
A348
A Meta Regression Analysis of Utility Weights for Breast Cancer
Gong, J. / Lim, J. / Bae, S. | 2016
A348
Prospective Utility Study of Patients with Multiple Cardiovascular Events
Pockett, R. / McEwan, P. / Ray, J. / Tran, I. / Shutler, S. / Martin, S. / Yousef, Z. / Bakhai, A. | 2016
A348
Utility By Treatment Line In Multiple Myeloma; Analysis of Over 9000 EQ-5Q-3L Questionnaires from the Emmos Registry
Hatswell, A. / Couturier, C. / Ito, T. | 2016
A348
A Review of the Use of Network Meta-Analysis In Nice Single Technology Appraisals
Fleetwood, K. / Glanville, J. / McCool, R. / Wood, H. / Wilson, K. / Marshall, C. / Yellowlees, A. / James, D. / Toupin, S. / McCabe, R. | 2016
A349
Policy Objective of Generic Medicines from the Investment Perspective: The Case of Clopidogrel
Elek, P. / Harsányi, A. / Zelei, T. / Csetneki, K. / Kaló, Z. | 2016
A349
Mapping Quality of Life Scores from FACT-G, FAACT And FACIT-F Onto Preference-Based Utilities Using the 5-Level Version of EQ-5D Questionnaire
Meregaglia, M. / Borsoi, L. / Cairns, J. / Tarricone, R. | 2016
A349
Are Component Endpoints Equal? A Study into the Practice of Composite End Points in Clinical Trials
Vaanholt, MC / von Birgelen, C / Kok, M / Weernink, MG / van Til, J | 2016
A349
Comparison of Oral Anti-Coagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation: Two Multi-Criteria Decision Analyses
Tervonen, T. / Ustyugova, A. / Lip, G. / Verdecchia, P. / Sri Bhashyam, S. / Heinrich-Nols, J. / Gropper, S. / Kwan, R. / Marsh, K. | 2016
A349
Using Subpopulation Treatment Effect Pattern Plot to Identify More Efficient Resource Allocation Policies
Cao, Q. / Hillege, J. / Postma, M. / Buskens, E. / Postmus, D. | 2016
A350
Real-World Impact Of Gender, Age And Socio-Economic Status On Type-2 Diabetes Mellitus (T2dm) Patients’ Disease Engagement And Adherence With Treatment Regimens
Higgins, V. / Leith, A. / Benford, M. / Siddall, J. / Piercy, J. | 2016
A350
Differences In Pricing Policies For Generic And Biosimilar Medicines
Vogler, S. / P, S. / Gombocz, M. / Zimmermann, N. | 2016
A350
The Determinants Of Innovative Drugs Prices: The Case Of Oncology Drugs, Comparative Analysis
Aissaoui, A. / Levy, P. | 2016
A350
Association Between The Prices Of Orphan Drugs In Oncology And The Patient Population Sizes
Jarosławski, S. / Toumi, M. | 2016
A350
Pay For Performance: A Proposal For And Simulation Of Real Time Outcomes-Based Pharmaceutical Pricing Using Routinely Collected Data
Butt, T. / Lee, A. / Tufail, A. | 2016
A351
A Framework For Measuring Adherence To Multiple Medications
Pednekar, P. / Agh, T. / Malmenas, M. / Peterson, A. | 2016
A351
ND1 Burden And Work Productivity Loss Impairment From Providing Care To Alzheimer's Disease Patients
Hu, X. / Wood, R. / Jones, E. / Black, C. / Khandker, R. / Ambegaonkar, B. | 2016
A351
Medication Adherence And Persistance In Type 2 Diabetes Mellitus (T2dm): Patients Perspective In Ths Spanish Health Care System
Labrador Barba, E. / Hernandez Mijares, A. / Alonso Moreno, F. / Rodriguez de Miguel, M. / Orera Peña, M. / Aceituno Mata, S. / Faus Dader, M. | 2016
A351
Adherence To Treatment And Modifiable Risk Factors In Acute Coronary Syndrome (Acs) Patients Registered In The Pgrx Real World Datasets
Cuervo, J. / Nordon, C. / Rossignol, M. / Morisot, N. / Benichou, J. / Danchin, N. / Abenhaim, L. / Grimaldi-Bensouda, L. | 2016
A351
Advanced Parkinson's Disease In Stockholm County, Sweden – How Many Are They And What Are The Real-Life Health Care Costs?
Eriksson, JK / Anell, B | 2016
A352
The Cost Of Multiple Sclerosis In 16 European Countries: Functional Status, Symptoms And Mental Factors Drive Costs
Berg, J. / Gannedahl, M. / Capsa, D. / Eriksson, J. / Thompson, A. / Kobelt, G. | 2016
A352
Nine Tests For Assesing Validity Of A Discrete-Choice Experiment
Janssen, E. / Bridges, J. | 2016
A352
Patients' Preferences For Characteristics Of Periodontal Disease And Its' Treatment: A Discrete Choice Experiment
Vennedey, V. / Danner, M. / Civello, D. / Schwalm, A. / Seidl, A. | 2016
A352
Excess Costs Associated With Obstructive Sleep Apnea In The Elderly
Menzin, J. / Park, S. | 2016
A352
Heterogeneous Preferences For Delaying Onset Of Alzheimer’s Disease Among Older Adults In The Us
Reed, S. / Yang, J. / Disantostefano, R. / Streffer, J. / Levitan, B. / Johnson, F. | 2016
A353
Criteria Driving Values Assessments in Multiple Sclerosis Medicines
Visintin, E. / Kanavos, P. | 2016
A353
HT5 Development of a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision-Making in Catalonia (Spain): Pilot Study Focused in Orphan Drugs
Gilabert-Perramon, A. / Torrent-Farnell, J. / Catalan, A. / Prat, A. / Fontanet, M. / Puig-Peiró, R. / Merino-Montero, S. / Khoury, H. / Goetghebeur, M. / Badia, X. | 2016
A353
Comparing Preferences Of Patients With Rheumatic Diseases, Of Experienced Rheumatologists, Nurses And Pharmacists Toward The Treatment Of Rheumatic Diseases With Biological Agents: Results From The Cara Study
Scalone, L. / Cortesi, P. / Sarzi-Puttini, P. / Sinigaglia, L. / Montecucco, C. / Giacomelli, R. / Lapadula, G. / Olivieri, I. / Giardino, A. / Mecchia, M. | 2016
A353
Defining the Value: Do the New Oncology Frameworks in the Us Aim at Objective Valuation? – A Case Study in Multiple Myeloma
Forsythe, A. / Pezalla, E. | 2016
A353
HTA Agencies Perspective on Progression-Free-Survival (PFS)
Schmitter, S. / Holzerny, P. / Brock, E. / Günzel, C. / Ruckdäschel, S. | 2016
A354
Cost Effectiveness of Nivolumab Monotherapy for the Treatment of Advanced Melanoma Patients in the United Kingdom
Meng, Y. / Hertel, N. / Ellis, J. / Johnson, H. / Philips, Z. / Roskell, N. / Lee, D. | 2016
A354
The Cost-Effectiveness of Bariatric Surgery in Germany, France, Italy and the United Kingdom
Belarbi, S. / Kusel, J. / Thomas, M. | 2016
A354
Is it Really Cost-Effective to Risk-Assess all Hospitalized Patients for Pressure Ulcers Every Nursing-Shift?
Padula, W. / Onyekwere, U. / Makic, M. / Wald, H. / Epstein, Z. / Meltzer, D. | 2016
A354
Economic Evaluation for the United Kingdom of Systemic Chemotherapies as First-Line Treatment for Metastatic Pancreatic Cancer
Gharaibeh, M. / McBride, A. / Alberts, D. / Slack, M. / Erstad, B. / Abraham, I. | 2016
A354
DB1 Mortality Excess Due To Clostridium Difficile Infection - A National Database Analysis
Bouee, S / Levy Bachelot, L / Ravonimbola, H / Longepierre, L / Godard, C / Gourmelen, J / Barbut, F | 2016
A355
A Retrospective Study on Association Between Change In Bmi And Incidence Of Hypertension Using A Health Care Database In Japan
Yamamoto, Y. / Tanabe, K. / Takahashi, S. / Ii, Y. / Kitazaki, S. / Fujimoto, Y. | 2016
A355
The Relationship Between Medical Innovation And Health Expenditures
Cinaroglu, S. / Guzel, E. / Baser, O. | 2016
A355
Use of Data-Mining to Perform a Real World Cost Analysis of Her2-Positive Breast Cancer In Iran
Ansaripour, A. / Zendehdel, K. / Tadayon, N. / Sadeghi, F. / Uyl-de Groot, C. / Redekop, W. | 2016
A355
Modeling The Impact Of Reform To The Cancer Drugs Fund
Karlsberg Schaffer, S. / Garau, M. / O'Neill, P. / Bianchi, S. | 2016
A355
Accuracy Of Natural Language Processing-Based Classifiers For Automated Identification Of Abstracts Of Studies On Humanistic And Economic Burden Of Disease
Krohn, J. / Martin, A. / Martin, C. | 2016
A355
Economic Burden Of Diseases In France: Analysing The Trends From 2012 To 2014, Using The French Health Insurance Database (Sniiram)
Gastaldi Menager, C. / Drouin, J. / Pestel, L. / Fagot-Campagna, A. / Gissot, C. | 2016
A356
Towards Improved Cervical Cancer Primary Screening in Austria - A Decision-Analytic Benefit-Harm Analysis
Sroczynski, G. / Esteban, E. / Widschwendter, A. / Oberaigner, W. / Borena, W. / von Laer, D. / Hackl, M. / Endel, G. / Siebert, U. | 2016
A356
Comparison Of Time To Reimbursement Decision Of Innovative Pharmaceuticals In Europe
Hernandez, J. / Nientker, K. / Hensen, M. | 2016
A356
Adoption of Transcatheter Mitral Valve Repair in Germany: Utilization Patterns and Case Volumes Compared to Mitral Valve Surgery in the Period 2010-2014
Pietzsch, J. / Weber, S. / Pietzsch, M. / Conradi, L. | 2016
A356
Decision Uncertainty and Need for Further Research: A Case-Study in Fenestrated Endovascular Aneurysm Repair for Complex Abdominal Aortic Aneurysms
Ciani, O / Epstein, D / Rothery, C / Taylor, RS / Sculpher, M | 2016
A356
MD1 Medical Devices: Timely Access and Reimbursement - Can National Health Technology Assessment Bodies Be Part of the Solution?
Macaulay, R. / Shaw, S. | 2016
A357
Causes of Death Statistics Underestimate the Burden of Head and Neck (H&N) Cancers: A Nationwide Study From France in 2008-2012 (Epicorl Study)
Thiébaut, S. / Even, C. / Pointreau, Y. / Geoffrois, L. / Bec, M. / Godard, C. / Levy-Bachelot, L. / Huguet, F. / Témam, S. / Schwarzinger, M. | 2016
A357
Comparison of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) and the American Society of Clinical Oncology (Asco) Framework for Assessing Value in Cancer Care
Rémuzat, C. / Chouaid, C. / Auquier, P. / Kornfeld, A. / Toumi, M. | 2016
A357
A Review Evaluating the Validity of Motion-Based Gaming Platforms to Measure Clinical Outcomes in Clinical Research
Byrom, B / Breedon, P / Muehlhausen, W | 2016
A357
Considerations in Meta-Analytic Network Design: The Case of Platinum Doublet Chemotherapies in Advanced Non-Small Cell Lung Cancer (Advnsclc)
Goring, S. / Scott, D. / Briggs, A. / Penrod, J. / Wilson, J. / Waser, N. / Thompson, J. / Korytowsky, B. / Chirita, O. / Wong, B. | 2016
A358
Guidelines for Translation and Cross-Cultural Adaptation of Non-Technical Skills Rating Instruments
Repo, J. / Rosqvist, E. | 2016
A358
Expected Impact of the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (Esmo-Mcsb) on Health Technology Assessment
Rémuzat, C / Chouaid, C / Auquier, P / Borget, I / Kornfeld, A / Toumi, M | 2016
A358
Evaluating the Quality of Evidence From the Aspire and Endeavor Clinical Trials Using the Grading of Recommendations, Assessment, Development and Evaluation (Grade) Approach
Biedermann, P. / Esposito, B. / Glen, C. / Pippo, L. / Avallone, G. / Gonzalez-McQuire, S. / Gatta, F. | 2016
A358
Psychometric Analyses of Clinical Outcome Assessment (Coa) Questionnaires Designed to Evaluate Satisfaction with Pharmacological Stress Agents (Psas) Used in Echocardiography
Spalding, J. / Hudgens, S. / Litcher-Kelly, L. / Shields, A. / Kitt, T. / Ojo, O. / Kristy, R. / Lee, E. / Mathias, A. / Morrissey, L. | 2016
A358
Man Versus Machine - Is Accurate Automation of Data Abstraction Achievable?
Kiff, C. / Scott, D. / Thompson, J. / Quigley, J. / Eaton, J. | 2016
A358
Single-Arm Trials in Systematic Reviews: Are They Adequately Captured by Existing Search Filters?
O'Rourke, J. / Ward, K. / Thompson, J. | 2016
A359
Analysis of the Asco Value Framework Net Health Benefit Score as A Tool for Assessing Novel Therapies in Relapsed/Refractory Multiple Myeloma (Rrmm)
Cork, D. / Nelson, L. / Curry, A. | 2016
A359
Applying The Accepted Techniques of Indirect Treatment Comparison to Meet Payer Needs For Brivaracetam Versus Adjunctive Antiepileptic Medications for The Treatment of Focal Seizures In Adult Patients. Do they reflect the need for individualised patient care in heterogeneous populations in epilepsy?
Charokopou, M. / Harvey, R. / Sristava, K. / Townsend, R. / Borghs, S. | 2016
A359
The American Society of Clinical Oncology (Asco) Net Health Benefit (Nhb) Assessment Tool: Which Implications for Value Assessment of Cancer Therapies?
Rémuzat, C / Chouaid, C / Auquier, P / Borget, I / Kornfeld, M / Toumi, M | 2016
A359
Weakness of Registration Bioequivalent Drugs
Krakowian, P. / Iwanczuk, T. / Zaremba, A. / Misiak, J. / Tatara, T. / Wysoczanski, W. | 2016
A359
Patience is a Virtue When Connecting Evidence Networks
Halfpenny, N. / Quigley, J. / Gurung, B. / Scott, D. | 2016
A360
Optimal Design of Pre-Authorization Trials for Effectiveness Evaluation in Severe Asthma
Karcher, H. / Meng, J. / Fu, S. / Loefroth, E. / Cao, H. / Peress, E. | 2016
A360
Developing A Classification System of Patients Based on Risk Related to Epidemiological and Demographic Variables
Romero Prada, M. / Marrugo, R. / Celis, S. / Alfonso Quiñones, P. / Vivas-Consuelo, D. | 2016
A360
Payer Requirements in the Treatment of Chronic Heart Failure
Bergenheim, K. / Hellsten Kronander, A. / Lauks, S. / van Engen, A. | 2016
A360
A New Model to Identify Multivariate Causes of High Cost in Patient With Advanced Liver Disease
Turri, J. / Ferreira, L. | 2016
A360
Application of A Value Framework Based on Multiple Criteria Decision Analysis in the Context of Health Technology Assessment: A Series of Case Studies with Decision Makers Across European Countries
Angelis, A. / Kanavos, P. | 2016
A361
Synthesis of Binary Outcome Data on the Log-Odds and Absolute Risk Scales – A Case Study in Chronic Hepatitis C
Nagy, L. / Kay, G. / Parker, C. / Padhiar, A. / O'Rourke, J. / Quigley, J. / Mealing, S. / Hawkins, N. | 2016
A361
Detection and Analysis of Therapy Lines and Other Event Sequences in Claims Data
Ertl, J. / Hapfelmeier, J. / Ansorge, S. | 2016
A361
Increasing the Interpretability of Patient-Reported Outcomes Questionnaire Findings Using A Mixed Methods Design: An Example in A Rare Cardiac Clinical Trial
Marrel, A. / Fofana, F. / Guillemin, I. | 2016
A361
Parametric Simulation of Headache Day Frequency Using A Negative Binomial Distribution: A Case Study of Erenumab in Episodic Migraine
Porter, J. / Brennan, A. / Palmer, S. / Sapra, S. / Cristino, J. | 2016
A361
Evaluating the Effectiveness of Treatments of Opioid use Disorder Based on Recovery Outcomes: How to Bridge the Disconnect Between Clinical Trial Outcomes and Recovery Outcomes?
Elroy, P. / Ronquest, N. / Barnes, A. / Nadipelli, V. / Akehurst, R. | 2016
A361
Differences in Perception of Health-Related Quality of Life Associates to Socioeconomic, Cultural and Housing Factors: Multilevel Analysis
Romero Prada, M. / Alvis Guzman, N. / Celis, S. / Huerfano, L. / Gallo, D. | 2016
A362
Four Decades of Rasch Analysis on Patient-Reported Outcomes Instruments Validation: A Systematic Literature Review
de Bock, E. / Williams, P. / Tugaut, B. | 2016
A362
Validating The Projected Mortality Rates Used in Oncology Cost-Effectiveness Analysis: A Pitfall of Simple Benchmarking With Life Table Age-Specific Mortality Rates for A Trial Population
Zhang, Y. / Dyer, M. / Vereecken, W. | 2016
A362
Review of Methods for Combining Individual and Aggregate Data in a Meta-Analysis
Kapso Kapnang, R. / Thokagevistk, K. / Vataire, A. / Aballéa, S. | 2016
A362
Epidemiological Profile of Knee Arthroplasty Surgery in Health Care System of Public Employees Located in Northeast Brazil Between July 2014 and December 2015
Silva, J. / de Souza, N. / Silva, S. / Novis, C. | 2016
A362
Evaluation of the Effect of Pharmaceutical Care Interventions on the Mean Daily Dose of Oral Antidiabetes Drugs in a Nigerian Tertiary Hospital
Ogbonna, B. | 2016
A362
Economic and Humanistic Impact Assumptions for Hypoglycemic Events: Implications for Cost-Effectiveness Analyses in Insulin-Treated Diabetes
Tunis, S. / Klinkenbijl, B. / Graham, C. / Weaver, D. | 2016
A363
Which costs matter? Costs included in economic evaluation and their impact on decision uncertainty: the example of acute myocardial infarction
Lomas, J. / Asaria, M. / Bojke, L. / Richardson, G. / Walker, S. | 2016
A363
Health Economic Costing Methods and Reporting in Austria
Mayer, S. / Kiss, N. / Laszewska, A. / Simon, J. | 2016
A363
Spill Over Economic Impacts on Families of Children Receiving Hospital-Based Care
Samnaliev, M. | 2016
A363
Comparing Different Data on Disease Burden In Multiple Sclerosis
Berg, J. / Gannedahl, M. / Capsa, D. / Kobelt, G. | 2016
A363
Valuing Cancer-Related Premature Mortality: A Comparison of Consumer-Led Versus Producer-Led Approaches
Hanly, P. | 2016
A364
A Systematic Literature Review (Slr) of Health-Economic Evaluations of Treatments for Rare Diseases
Garcia Sanchez, J. / Norman, D. | 2016
A364
Evaluating Therapeutic Treatments for Psoriatic Arthritis: Can We Make Better use of Patient Data Registries?
Walton, M. / Bojke, L. / Manca, A. / Patton, T. | 2016
A364
Three Methods for Measuring Productivity Losses Due to Health Related Presenteeism in Economic Evaluations
Shephard, C. / Hirst, A. / Buckland, A. / Vlachaki, I. / Wang-Silvanto, J. | 2016
A364
Valuing Informal Care: Making Normative Judgments in A Positive Milieu
Hanly, P. / Maguire, R. / Balfe, M. / Sharp, L. | 2016
A364
Challenges in Economic Evaluations Conducted Alongside Clinical Trials of Schizophrenia: The Case of the Actions Study
Kiss, N. / Simon, J. | 2016
A364
Systematic Review of Budget Impact Analysis on Vaccines
Itria, A. / Loze, P. | 2016
A365
How time and severity increases the overall cost and resource utilization of patient with severe liver disease. Main burdens and consequences to health system
Turri, J. / Ferreira, L. | 2016
A365
The value of timely implementation in hiv/sti testing: cost-effectiveness vs. Speed of intervention rollout
Beck, E. / Armbruster, B. / Birkett, M. / Mustanski, B. | 2016
A365
The Economic Burden of Pulmonary Embolism in Europe
Gumbs, P. / Ling-Hsiang Chuang, L. / Cohen, A. / Agnelli, G. / Willich, S. / Monreal, M. / Jimenez, D. / van Hout, B. | 2016
A365
The Cost-Effectiveness of Blue-Light Therapy Vs Fixed Combination of Calcipotriol and Betamethasone Dipropionate Gel in the Treatment of Mild-To-Moderate Psoriasis
Ansaripour, A. / Thio, H. / Maessen, R. / Redekop, W. | 2016
A365
A General Model for The Estimation of Societal Costs of Lost Production and Informal Care In Italy
Pradelli, L. / Ghetti, G. | 2016
A365
Cost-Effectiveness of Brivaracetam Versus Other Antiepileptic Drugs Used as Adjunctive Treatment for Focal Seizures in the Uk: A Discrete Event Simulation Model
Charokopou, M. / Sander, J. / Saha, R. / Beard, S. / Kidd, R. / Coward, E. / Plumb, J. | 2016
A366
Appropriate Analysis of the Additional Costs of Antibiotic Resistance: The Impact of Different Biases
Kaier, K. / Heister, T. | 2016
A366
Conceptual Modelling for Cost-Effectiveness Analysis of Intravitreal Therapy with Ranibizumab, Aflibercept or Bevacizumab for Macular Oedema Due to Central Retinal Vein Occlusion
Goodall, M. / Tosh, J. / Alshreef, A. / Tappenden, P. | 2016
A366
Challenges in the Health Economics of Acute Pain: A Rapid Review of the Literature
Braileanu, G. / Johnson, B. / Ashraf, S. / Borrill, J. / Hirst, M. | 2016
A366
Challenging Model Complexity; A Simpler Approach For Developing Markets
Marijam, A. | 2016
A366
The Benefits of A Holistic View: Considering Multiple Health Outcomes for Hiv and Sti Testing
Beck, E. / Armbruster, B. / Birkett, M. / Mustanski, B. | 2016
A367
Accuracy Of Text Processing Tokenisers For Automated Identification Of Diseases And Interventions In Abstracts Of Studies On Humanistic And Economic Burden Of Disease
Challen, R. / Martin, A. / Martin, C. | 2016
A367
Eliciting Payers Preferences In Central And Eastern Europe: Results Of Mcda Case Study
Piniazhko, O. / Zalis'ka, O. / Zah, V. | 2016
A367
Comparison Of Estimated Effectiveness Of Biologics For Rheumatoid Arthritis (Ra) In Large Insurance Databases Using A Claims-Based Algorithm
Rascati, K. / Popp, R. / Davis, M. | 2016
A367
Viability Of Using Electronic Medical Records From European Countries As Data In Novelty (A Novel Observational Longitudinal Study Of Patients With Asthma And/Or Copd)
Wang, X. / Sveréus, A. / Rennard, S. / Hiller, J. / Wong, D. / Nasuti, P. / Jenner, H. / McKenney, A. / Gerhardsson de Verdier, M. | 2016
A367
Identifying Potential Early Biomarkers Of Acute Myocardial Infarction In The Biomedical Literature: A Comparison Of Text Mining And Manual Sifting Techniques
Paisley, S. / Seva, J. / Stevenson, M. / Archer, R. / Preston, L. / Chilcott, J. / Thornhill, M. | 2016
A367
Linkage Of The Pharmo Database Network And The Netherlands Perinatal Registry To Construct A Cohort That Captures Pregnancy And Postnatal Outcomes
Houben, E. / Bezemer, I. / Herings, R. | 2016
A368
Use Of Surveillance Databases To Describe Influenza Epidemiology In Europe
Riera, M. / Ferreira, G. / Cattaert, T. / Verstraeten, T. | 2016
A368
The Use Of Administrative Data To Determine Prevalence And Incidence Of Copd: A Systematic Review
Gothe, H. / Rajsic, S. / Gottfried, E. / Vukicevic, D. / Siebert, U. | 2016
A368
Artificial Integligence To Support The Development Of Health Technology Assessment Reports
Sekiewicz, B. / Rodak, W. / Rutkowski, J. / Plisko, R. / Miazga, P. | 2016
A368
Pediatric Registry Of Patients With Severe Persistent Uncontrolled Asthma Receiving Omalizumab
Namazova-Baranova, L. / Vishneva, E. / Dobrynina, E. / Alekseeva, A. / Levina, J. / Efendieva, K. / Smirnov, V. / Antonova, E. / Voznesenskaya, N. / Selimzianova, L. | 2016
A368
Ethical Standards In Reporting Research From Retrospective Observational Studies Based On Databases Using Anonymous And Personally Unidentifiable
Hiroi, S. / Uda, A. / Tokaji, A. / Takeshima, T. / Iwasaki, K. | 2016
A369
Markov Models For Health Economic Evaluation Modelling In R With The Heemod Package
Filipovic-Pierucci, A. / Zarca, K. / Durand-Zaleski, I. | 2016
A369
An Investigation Into Open-Source Modelling In Health Economics: Opportunities And Challenges
Mason, N. / Kenworthy, J. / Akehurst, R. / Sullivan, W. / Dunlop, W. | 2016
A369
Prediction Of Costs Associated With The Hospital Management Of Hiv Patients In France Using An Advanced Data Mining Approach On The French Medical Information System Database
Prodel, M. / Amaz, C. / Vainchtock, A. / Finkielsztejn, L. / Aubin, C. | 2016
A369
Development Of A Search Engine For The Medline Database With Search Results Ranking From The Perspective Of Evidence-Based Medicine
Kolbin, A. / Kamalov, M. / Dobrynin, V. / Balykina, Y. / Verbitskaya, E. | 2016
A369
Proqolid Database: Evolution Of Content, Structure, And Functionalities (2012-2016) - Integration In Eprovide, A New Online Platform Dedicated To Clinical Outcome Assessment (Coa) Research
Perret, C. / Perrier, L. / Castex, M. / Acquadro, C. | 2016
A369
Measures Taken By The Romanian Ministry Of Health For Better Access To Anti-Egfr Drugs
Turcu-Stiolica, A. / Subtirelu, M. / Mic, O. | 2016
A370
Mapping The Involvement Of Eunethta Participants In Eu Research Projects
Kozák, A. / Hankó, B. / Lám, J. / Merész, G. | 2016
A370
Characteristics Of A Patient Population Recruited Using Social Media (Facebook) Compared With Newspaper Advertising (Daily Mail)
Wade, A. / Crawford, G. / McLennan, K. | 2016
A370
Expert Elicitation: Can Variation In Elicited Distributions Be Explained By Expert Heterogeneity?
Jankovic, D. | 2016
A370
Evaluating Socio-Demographic Characteristics Of Patients In The United States Department Of Defense Population
Wang, L. / Li, L. / Pandya, S. / Baser, O. | 2016
A370
Network Analysis Approach To Explore Sponsor Involvement In Clinical Trials
Merész, G. / Kozák, A. / Hankó, B. / Szócska, M. | 2016
A371
A Systematic Review on the Evidence of Adequate Discount Rates for Vaccines in Germany
Koerber, F. / Redeker, M. / Wieninger, E. / Welte, R. | 2016
A371
Analysis of the Relationship Between Blood Pressure in Health Checkup and Effectiveness of Antihypertensives
Koizumi, H. / Nakamura, Y. / Iwasaki, K. / Hiroi, S. / Uda, A. / Shimasaki, Y. | 2016
A371
Quinolones Utilization In Two Tertiary Hospitals In Nigeria; Exploring Drug Use Towards Improved Treatment Outcomes
Ogbonna, B. | 2016
A371
Implications of Introducing Patient Heterogeneity in Cost Effectiveness Modeling
Foos, V. / McEwan, P. / Lamotte, M. | 2016
A371
Not All Cochrane Reviews Are Good Quality Systematic Reviews
Deshpande, S. / Misso, K. / Westwood, M. / Stirk, L. / de Kock, S. / Kleijnen, J. / Clayton, D. | 2016
A371
Missing the Value of Herd Immunity in Cost-Effectiveness Analysis. A Systematic Review
Nymark, L. | 2016
A372
Empirical Assessment of the Impact of Model Choice (Markov State Transition Versus Partitioned Survival) in Modelling Small-Cell Lung Cancer
McEwan, P. / Gordon, J. / Ward, T. / Penrod, J. / Yuan, Y. | 2016
A372
The Implications of Parameter Independence in Probabilistic Sensitivity Analysis
Taylor, M. | 2016
A372
Comparison of Markov Models Used for the Economic Evaluation of Colorectal Cancer Screening: A Systematic Review
Silva, N. | 2016
A372
Replacing Input Probability Distributions with Mean Values can Bias Simulation Output: An Illustration Using the Core Diabetes Model
McEwan, P. / Foos, V. / Lamotte, M. | 2016
A372
Structured Review of Health Economic Models in Asthma
Enstone, A. / Price, G. / Viejo, I. / Dunlop, W. | 2016
A373
Automatic Extraction and Classification of Patients’ Smoking Status from Free Text Using Natural Language Processing
Caccamisi, A. / Jörgensen, L. / Dalianis, H. / Rosenlund, M. | 2016
A373
Review of Health Economic Models for Antibiotics
Virhage, M. / Polyzoi, M. / Geale, K. / Corcoran, K. / Anell, B. | 2016
A373
Recommendations for the Calculation of Transition Probabilities in Markov Cohort Models: A Targeted Literature Review
Olariu, E. / Cadwell, K. / Fox, D. / Hancock, E. / Trueman, D. / Ratcliffe, M. / Grieve, R. / Chevrou-Severac, H. | 2016
A373
Potential Efficacy of Lomitapide, A MTP (Microsomal Triglyceride Transfer Protein) Inhibitor, on Survival in Homozygous Familial Hypercholesterolaemia (HOFH): Results of an Event Modelling Analysis
Leipold, R / Raal, F / Ishak, J / Phillips, H / Deanfield, J | 2016
A373
To What Extent Does the Published Economic Analyses of Treatments for Opioid Use Disorder Capture its Chronic, Relapsing Nature and its Impact on Society?
Cranmer, H. / Ronquest, N. / Barnes, A. / Nadipelli, V. / Akehurst, R. | 2016
A373
Modelling the Cost-Effectiveness of Treatment Strategies in Chronic Lymphocytic Leukaemia, Follicular Lymphoma and Multiple Myeloma: A Review and Critical Appraisal of the Published Literature
Kankeu, T. H. / Manca, A. | 2016
A374
Accounting for the Imperfect External Validity of Discrete Choice Experiments When Predicting Demand
Quaife, M. / Terris-Prestholt, F. / Di Tanna, G. / Vickerman, P. | 2016
A374
Extrapolation with Patient Level Time-To-Event Data in Various Disease Areas: A Review of Current Recommendations and Gaps
Kamra, S / Kaur, J / Kartheek, J / Sehgal, M / Siddiqui, MK | 2016
A374
The Impact of the Difference in Natural History Models on the Cost-Effectiveness of Antiviral Agents for Patients with Genotype 1 Chronic Hepatitis C
Ishida, H. / Ikai, H. / Suenaga, R. / Suka, M. / Hirao, T. | 2016
A374
Deterministic Vs Microsimulation; A Case Study In Systemic Lupus Erythematosus (SLE)
van Oostrum, I. / Guenther, O. / Postma, M. / Heeg, B. | 2016
A374
Use of the Pert and Uniform Distributions with the Central Limit Theorem (CLT) to Decrease Variance in Complication Cost Estimation in Probabilistic Models
Reynecke, D. / Robson, J. | 2016
A375
Evaluation of Methodological Variations in the Event Simulation Approaches of Published Health Economic Models in Obesity Prevention and Therapy
Schwander, B. / Nuijten, M. / Hiligsmann, M. / Evers, S. | 2016
A375
Sampling of Commonly used Population Characteristics: Is A Normal Approximation Valid?
Davis, J. / Mittard, V. / Saunders, R. | 2016
A375
Systematic Review of Cost-Effectiveness Models in Diabetes for Insulin Analogues
Ng, C. / Shafie, A. / Chaiyakunapruk, N. / Tan, Y. | 2016
A375
Identifying the Key Parameters of the European-Study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) Model
Nemeth, B. / Kulchaitanaroaj, P. / Lester-George, A. / Huic, M. / Pokhrel, S. / Coyle, D. / Coyle, K. / Kaló, Z. / Józwiak-Hagymásy, J. | 2016
A375
Cost-Effectiveness Depends on the Subsequent Treatment Sequence: An Example from Multiple Sclerosis
Asseburg, C. / Svensson, J. / Andersson, E. / Persson, U. / Willis, M. | 2016
A376
A Novel Method for Evaluating Value Assessment Frameworks
Bentley, T. / Cohen, J. / Elkin, E. / Huynh, J. / Mukherjea, A. / Neville, T. / Mei, M. / Copher, R. / Knoth, R. / Popescu, I. | 2016
A376
Diversity in Economic Evaluations Hampers Valid Decision-Making in Metastatic Colorectal Cancer
Merkens, G. / Tamminga, H. / Hovels, A. / Frederix, G. | 2016
A376
Multithreading: Turbocharged Cost-Effectiveness Analyses in Microsoft Excel
Kiff, C. / Mealing, S. / Fenwick, E. | 2016
A376
Treatment Efficacy in Sequence Modelling – A Review of Published Approaches
Polyzoi, M / Medin, E | 2016
A376
How are Adverse Effects Incorporated in Cost-Effectiveness Models? A Study of Current Practice in Oncology Studies Submitted to HAS
Pibouleau, L. / Drezet, A. / Cognet, M. / Scemama, O. / Le galès, C. | 2016
A376
How to Handle Data Quality Issues in EQ-5D-5L Valuation Studies. The Spanish Case
Ramos-Goñi, J. / Craig, B. / Oppe, M. / Ramallo-Fariña, Y. / Pinto-Prades, J. / Luo, N. / Rivero-Arias, O. | 2016
A377
Hyperbolic Discounting of Effects in Economic Evaluations
Fókás, L. | 2016
A377
Requirements for Economic Evidence Across Different HTA Bodies
Vlachaki, I. / Wang-Silvanto, J. / Shephard, C. / Hirst, A. | 2016
A377
The Application of Population Models to Improve Access to Medical Innovations and Population Health – A Systematic Review
Jahn, B. / Conrads-Frank, A. / Sroczynski, G. / Rochau, U. / Zauner, G. / Bundo, M. / Gyimesi, M. / Endel, G. / Popper, N. / Siebert, U. | 2016
A377
Current Issues and Future Research Priorities for Health Economic Modelling of at Risk Population for Alzheimer’s Disease/Dementia
Gustavsson, A. / Green, C. / Jones, R. / Simsek, D. / de Reydet de Vulpillieres, F. / Adlard, N. / Bhattacharyya, S. / Wimo, A. / Förstl, H. / Luthman, S. | 2016
A377
A Review on the Current Status of Health Economic Modeling in Personalized Medicine
Degeling, K. / Koffijberg, H. / IJzerman, M. | 2016
A378
An Exploration of Techniques for Addressing Uncertainty in Survival Estimates used Within Partitioned-Survival Models
Bullement, A. / Critchlow, S. | 2016
A378
Adaptive Prediction of Symptoms Return Upon Discontinuation of Omalizumab Treatment in Chronic Spontaneous Urticaria Patients
Saldana Miranda, D. / Ferrer, M. / Janssens, N. / Gimenez-Arnau, A. / Balp, M. / Khalil, S. / Risson, V. | 2016
A378
Mathematical Model to Synthesize Natural History of Tick Borne Encephalitis and Lyme Borreliosis for the Purpose of Cost-Effectiveness Analysis
Mihajlovic, J. / Hovius, J. / Sprong, H. / Strle, F. / Bogovic, P. / Postma, M. | 2016
A378
Three-Monthly Long-Acting Formulation of Paliperidone Palmitate is a Dominant Treatment Option, Cost Saving While Adding Qalys, Compared to the One-Monthly Formulation in the Treatment of Schizophrenia in France
Arteaga Duarte, C. / Colin, X. / De Moor, R. / Guillon, P. / van Gils, C. | 2016
A378
Estimating the Appropriate Price Discounts for Biosimilars in the Treatment of Rheumatoid Arthritis in the Nordic Setting Using an Excel-Based Interactive Tool
Mahon, R. / Cassel, T. / Balkin, P. / Burke, C. / Bhattacharyya, S. / Gokhale, S. / Handin, J. / Mendoza, C. | 2016
A379
Influence of Air Pollution on Some Pregnancy Outcomes and Burden of Pneumonia on Children Under Five Years Old in Mongolia
Dorj, G. / Gendenragchaa, B. / Sanjjav, T. | 2016
A379
Understanding the Policy-Relevant Portion of the Efficient Frontier in Screening Interventions: The Importance of Comparator Strategies
O'Mahony, J. | 2016
A379
Do Health Technology Agencies Accept Methods for Dealing with Treatment Switching and Immature OS Data?
Zhang, Y. / Wright, J. / Luke, S. / Ryan, J. / van Engen, A. | 2016
A379
Investigating the Implementation of Adverse Events in Economic Models: A Systematic Literature Review in Multiple Sclerosis and Human Immunodeficiency Virus
Gillies, H. / Polyzoi, M. / Medin, E. | 2016
A379
The Importance of Model Conceptualisation: A Case Study in Ankylosing Spondylitis (AS) and Non-Radiographic Axial Spondyloarthritis (NR-AXSPA)
Sideris, E. / Soares, M. / Palmer, S. | 2016
A379
Mapping the Irritable Bowel Syndrome Quality of Life Measure (IBS-QOL) to EQ-5D in Patients with Irritable Bowel Syndrome with Diarrhoea (IBS-D)
Bjorner, J. / Rendas-Baum, R. / Carson, R. / Boer, R. / Tucker, C. / Andrae, D. / Brazier, J. | 2016
A380
Comparative Efficacy of Time to Virologic Suppression in Treatment-Naive HIV-1 Patients: A Network Meta-Analysis of Longitudinal Data
Snedecor, S. | 2016
A380
Defining Real-World Product Performance Using Survival Analysis and Superivsed Machine Learning
Geldof, T. / van Dyck, W. / Moreau, Y. | 2016
A380
Comparison Study Based on Simulation of Patient Pathways Using Multi-State Models in Oncology
Rakonczai, P. / Lang, Z. / Balazs, T. / Bacskai, M. | 2016
A380
Pharmacological Interventions for Familial Hypercholesterolaemia in Children and Adolescents: An Exploratory Evaluation using Advanced Hierarchical Network Meta-Analysis Techniques
Langford, B. / Wickstead, R. / Marsh, W. / Beale, R. / Evans, J. / Kusel, J. / Griffiths, M. | 2016
A380
Investigating the Effects of Testing and Adjusting for Nonlinearity using Categorization in Prediction Models with Costs as Outcome
Brouwers, D. / Nieboer, D. / Bosmans, J. / van Tulder, M. / Heymans, M. / van Dongen, J. | 2016
A381
Predicting Patient-Reported Outcomes from Disease-Specific Questionnaires: A Comparison of Seven Methodologies
Gheorghe, M. | 2016
A381
Statistical Models to Predict Indication of Respiratory Patients Between Asthma and COPD
Ilgin, Y. / Staus, A. / Chauvin, F. / Leheyda, N. / Wolk, A. / Witte, M. / Subramani, S. | 2016
A381
Methodological Review of Survival Models: Application to A Persistence Analysis Based on Long Acting Parenteral Antipsychotic in Retail Pharmacies in France
Harmand, S. / El Mouaddin, N. | 2016
A381
Brain Metastasis Prediction in Breast Cancer Women: Usefulness of Mathematical Modeling of Montecarlo
Sat-Muñoz, D / Balderas-Peña, L / Cruz-Corona, E / Ortiz-González, F / Chagollán-Ramírez, J / Chávez-Hurtado, J | 2016
A381
Generalising Results from Cost-Effectiveness Analysis: A Comparison of Methods to Account for Covariates
Mantopoulos, T. / Dias, S. / Welton, N. | 2016
A382
Lenalidomide for Treating Multiple Myeloma After 1 Prior Treatment; An Application of Multi-State Markov Modelling for the Extrapolation of Patient Level Survival Data
Saunders, O. / Gregory, J. / Lee, D. / Farrell, J. | 2016
A382
Developing A Conceptual Framework and a Tool for Measuring Absorptive Capacity in Pharmaceutical Companies
Sanati, E / Kebriaeezadeh, A / Davari, M / Abdollahi asl, A / Keshavarz, K | 2016
A382
Reflecting Uncertainty in Early HTA When Evidence on Parameter Distributions is Lacking: A Comparison of Methods
Koffijberg, H. / Degeling, K. / Janssen, M. / IJzerman, M. | 2016
A382
Correctly Capturing Uncertainty in Treatment Effects in Simulation Modeling
Willis, M. / Asseburg, C. | 2016
A382
Boosting a Modeller's Armoury: Pursuing Realistic and Efficient Competing Risk Health Economic Models (HEMS)
Kay, S. | 2016
A382
Methods for Time-Varying Exposure – A Literature Review
Linder, M. / Vago, E. / Bahmanyar, S. / Heeg, B. / Myers, D. / Zhang, M. / Andersen, M. | 2016
A383
Quality of Life of Patients Treated for Multiple Myeloma (MM) in France in a Real-World Setting
Despiegel, N. / Touboul, C. / Flinois, A. / Saba, G. / Gonzalez-McQuire, S. / Suzan, F. / Blachier-Poisson, C. / Guilhaume, C. | 2016
A383
Key Aspects in the Modelling of Dengue Transmission: Results from a Focused Literature Review
Kharitonova, E. / Aballea, S. / Knerer, G. | 2016
A383
Using Acoustic Simulations of Hearing Loss to Describe Health States: Are they Feasible and Reliable to use?
Williams, N. / Pierzycki, R. / Akeroyd, M. / Kitterick, P. | 2016
A383
Development of a Responder Definition for the Migraine Physical Function Impact Diary (MPFID)
Kawata, A. / Hsieh, R. / Sapra, S. / Desai, P. / Ortmeier, B. / Poon, J. / Tepper, S. / Stewart, W. / Dodick, D. / Hareendran, A. | 2016
A383
Further Validation of the Haemopref in a Real-World Setting
Tolley, C. / Staunton, H. / Brohan, E. / Spurden, D. / Cicchetti, M. / Cappelleri, J. | 2016
A384
Valuation of EQ-5D-5L Health States: A Comparison of Three Asian Countries
Luo, N. / Wang, P. / Liu, G. / Juntana, P. | 2016
A384
A New Approach to Presenting Health States in Stated Preference Valuation Studies
Cole, AM / Shah, K / Mulhern, B / Feng, Y / Devlin, N | 2016
A384
External Validity at Stake in Mapping Non-Preference Based Disease Specific Measures to Generic Preference-Based Utility Values in Advanced Cutaneous Melanoma
Franken, M. / Leeneman, B. / Jochems, A. / Schouwenburg, M. / Aarts, M. / van Akkooi, A. / van den Berkmortel, F. / van den Eertwegh, A. / Groenewegen, G. / de Groot, J. | 2016
A384
An International Patient Survey on Health Related Quality of Life Aspects not Cpatured by EQ-5D-5L
Mossman, J. / Efthymiadou, O. / Kanavos, P. | 2016
A384
Measuring Caregiver Quality of Life; Which Aspects Really Matter?
Efthymiadou, O. | 2016
A385
Psychometric Validation of the Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT®) Questionnaire
Gomberg-Maitland, M. / Channick, R. / Chin, K. / Fischer, A. / Frantz, R. / Roberts, L. / Miller, C. / Hunsche, E. / Zamanian, R. / Zastrow, M. | 2016
A385
The Quality-Adjusted Time Without Symptoms and Toxicity (Q-TWIST) in (IMMUNO)-Oncology: A Systematic Review of the Literature
Wan, Y. / Tai, M. / Botteman, M. | 2016
A385
An Anchor-Based Approach to Define an Impaired Day in Migraine Patients Utilizing the Migraine Physical Function Impact Diary
Kawata, A. / Hsieh, R. / Sapra, S. / Desai, P. / Ortmeier, B. / Gleeson, S. / Revicki, D. / Lipton, R. / Bayliss, M. / Hareendran, A. | 2016
A385
To Treat or Watch? Identifying Drivers of Decisions for Patients with GEP-NET Using Reflective Multi-Criteria Decision Analysis
Goetghebeur, MM / Samaha, D / Khoury, H / O'Neil, B / Lavoie, L / Bennetts, L / Wagner, M / Badgley, D / Gabriel, S / Berthon, A et al. | 2016
A385
Development of a Mapping Algorithm Between the SGRQ and EQ-5D-5L Utility Values in a Severe Asthma Population
Willson, J. / Mukuria, C. / Labeit, A. / Gunsoy, N. / Starkie Camejo, H. / Alfonso-Cristancho, R. / Brazier, J. | 2016
A386
Development and Content Validity of the Advanced Systemic Mastocytosis Symptom Assessment Form (ADVSM-SAF)
Evans, E. / Taylor, F. / Patki, A. / Ojo, O. / Lamoureux, R. / Horny, H. / Reiter, A. / Gotlib, J. / Shields, A. | 2016
A386
Eliciting Stated Preferences Regarding Life Extensions Near the End of Life: A Pilot Study for a Refinement of the Qaly
Taylor, M / Filby, A / Elvidge, JS | 2016
A386
Using Orthogonal Design in Selecting Health States for the Construction of EQ-5D-3L Value Set
Yang, Z. / Luo, N. / van Busschbach, J. / Stolk, E. | 2016
A386
Analyzing a German Index for the EQ-5D-5L Based on Experienced Health
Leidl, R. / Reitmeir, P. | 2016
A386
The Impact of Country-Specific Utility Tariffs on the Outcome of Cost-Utility Analyses; A Case Study
Bosmans, J. / Rossenaar, M. / van Dongen, J. / van Tulder, M. | 2016
A386
Conceptual Model and Clinical Outcomes Assessments for Angelman’s Syndrome: Utilizing Pragmatic Methods in Rare Diseases
Abetz-Webb, L. / Cabo, R. / Grieco, J. / Rakhit, A. / During, M. | 2016
A387
Health-Related Quality of Life in Opioid use Disorder Measured by Utilities: A Systematic Literature Review
Cranmer, H. / Ronquest, N. / Barnes, A. / Nadipelli, V. / Akehurst, R. | 2016
A387
Reconsidering EQ-5D; Quality of Life Domains that are Important for Multiple Sclerosis Patients
Mossman, J. / Efthymiadou, O. / Tinelli, M. / Kanavos, P. | 2016
A387
What Matters Most? An Exploration of Decision Criteria Considered by Patients with GEP-NET and Physicians Using Holistic Multi-Criteria Decision Analysis
Goetghebeur, M. / Samaha, D. / O'Neil, B. / Khoury, H. / Bennetts, L. / Lavoie, L. / Wagner, M. / Badgley, D. / Gabriel, S. / Berthon, A. | 2016
A387
"Why Can't I Just Use Google Translate?" A Study on the Effectiveness of Online Translation Tools in Translation of Coas
Lear, A. / Oke, L. / Forsythe, C. / Richards, A. | 2016
A387
A Systematic Review of Utility Derivation Methods: Time Trade off in Comparison to EQ-5D
Vollmer, L. / Shannon, R. / Walzer, S. | 2016
A388
Qualitative Research Approaches In Rare Diseases: Acid Sphingomyelinase Deficiency (ASMD) Symptoms and Impact as Reported by Patients and Caregivers
Avetisyan, R. / Hareendran, A. / Stringer, S. / Tan, S. / Sanson, B. / Hass, S. | 2016
A388
Content Validation of the Pulmonary Arterial Hypertension Symptoms and Impact (PAH-SYMPACT®) Questionnaire
Gomberg-Maitland, M. / Channick, R. / Chin, K. / Fischer, A. / Frantz, R. / Roberts, L. / Miller, C. / Hunsche, E. / Zamanian, R. / Badesch, D. | 2016
A388
Fore! Sweeping Generalisations do not Bowl Over all Cultures… Cultural Adaptation in the Kidney Disease Quality of Life Questionnaire
Richards, A. / Mead, H. / Towns, L. | 2016
A388
Systematic Review of Psychometric Properties of The EQ-5D Questionnaires In Patients with Hematologic Malignant Neoplasms
Mlynczak, K. / Wojcik, A. / Golicki, D. | 2016
A388
A Study of the Successful Adaptation of the Quality of Life Questionnaire - Bronchiectasis From Paper To Electronic Format
Simpson, H. / Ong, S. / Quittner, A. / McEvoy, K. / Dhariwal, M. | 2016
A389
Using Analytic Hierarchy Process to Weight Patient-Relevant Outcomes in the Treatment of Psoriasis for Calculating the Patient Benefit Index
Gutknecht, M / Danner, M / Augustin, M | 2016
A389
Understanding the Utility Value of Patients with Heavily Pre-Treated Multiple Myeloma
Hadi, M. / Swinburn, P. / de Freitas, H. / Ito, T. | 2016
A389
Comparing The EQ-5D-5L Value Sets Across Diferent Countries – Impact on Inpertretation of Clinical Study Results
Gerlinger, C. / Bamber, L. / Leverkus, F. / Schwenke, C. / Haberland, C. / Schmidt, G. / Endrikat, J. | 2016
A389
Well-Being: What Is It, How Does it Compare to Health and What are the Implications of Using it to Inform Health Policy?
Brazier, J. / Mukuria, C. / Peasgood, T. / Bjorner, J. | 2016
A389
Cross-Cultural Adaptation of the Zarit Caregiver Interview for Alzheimer's Disease (ZCI-AD) and the Caregiver Global Impression Scales in 13 Languages
Le Scouiller, S. / Edgar, C. / Rylands, A. / Giroudet, C. / Regnault, A. / Zarit, S. / Rofail, D. | 2016
A389
Translatability Evaluation of the Rome IV Diagnostic Questionnaire for Adults
Crane, A. / Popielnicki, A. / Sperber, A. / Drossman, D. / Palsson, O. / Whitehead, W. / Sweeney, E. / O'Brien, K. | 2016
A390
Performance of Search Filters to Identify Health State Utility Studies
Arber, M / Garcia, S / Veale, T / Edwards, M / Shaw, A / Glanville, J | 2016
A390
Translation of the DN4 (Douleur Neuropathique EN 4 Questions) INTO 85 Languages: Challenges and Importance of the Conceptual Defintion of the Original Version
Bouhassira, D. / Dulac, M. / Bindi, P. / Nguyen, A. / Acquadro, C. | 2016
A390
Euroqol To Assess The Quality of Life with Smartphone
Vorobiev, A. / Vorobiev, P. / Krasnova, L. / Vorobiev, M. | 2016
A390
Translation of Chinese Version of Measure Yourself Medical Outcome Profile (MYMOP) And Application In The Coronary Heart Disease
Zhang, F. / Zhang, S. / Wang, Y. / Zhang, Z. / Yang, G. | 2016
A390
Multiple Myeloma and Health-Related Quality of Life from EQ-5D and EORTC: A Systematic Literature Review
Jahn, B. / Vukicevic, D. / Jevdjevic, M. / Holzner, B. / Kemmler, G. / Siebert, U. / Rochau, U. | 2016
A391
Viewpoints of Thalassaemia Patients on the Combination of Traditional & Complementary Medicine (T&CM) with the Conventional Thalassaemia Treatment:A Qualitative Understanding Approach
Ismail, wI / Hassali, MA / Farooqui, M / Saleem, F | 2016
A391
Recommendations on Cognitive Debrief and Usability Studies for Instrument Migration from Paper to Electronic Modalities Based on A Qualitative Synthesis of Validation Studies
Muehlhausen, W. / Byrom, B. / Skerritt, B. | 2016
A391
When Should Translations of Clinical Outcome Assessments (COAS) be Considered Obsolete? Recommendations from MAPI’S Translations Life Expectancy Working Group
Giroudet, C. / Salmassi, L. / Prill, M. / Berne, C. / Berrou, M. / Boudrot, A. | 2016
A391
Linguistic Validation of the Injection-Treatment Acceptance Questionnaire (I-TAQ)
Crane, A. / Popielnicki, A. / Sanchez, R. | 2016
A391
Development of a Guidance on the Implementation and use of EORTC Instruments in Electronic Applications
Kulis, D. / Bottomley, A. / Holzner, B. / Koller, M. / Swinburn, P. / Itani, A. | 2016
A391
Linguistic Validation and Electronic Migration of the Kansas City Cardiomyopathy Questionnaire (KCCQ)
Sydor, B. / Spertus, J. | 2016
A392
Comparison of Methods for Indirect Treatment Comparison Combining Individual and Aggregate Patient Data: A Simulation
Rasouliyan, L | 2016
A392
An a Priori Decision Criteria Elicitation Method for Treatment Decision-Making in Elderly Colorectal Cancer Patients
Keizer, J. / IJzerman, M. / van Til, J. / Wymenga, A. | 2016
A392
Incorporating Biometric Data from Wearable Activity Trackers with Study Data in France and the UK
Fink, L. / Chanot, G. / Bernard, F. / Mondry, B. / Bondarenko, K. | 2016
A392
The Economic Impact of Influenza-Like Illness on Families Living in the UK Demonstrated by the Collection of Online Data
Wade, A. / Crawford, G. / McLennan, K. | 2016
A392
Watch Out for Berkson's Bias (BB)! Setting Health-Related Quality of Life (HRQOL) Treatment Targets with Matching-Adjusted Indirect Comparison (MAIC) in Order to Predict Matched General Population Control (MGPC) Targets, Assess Potential to Benefit (PTB) and Reveal Unmet Medical Need (UMN)
Soini, E. / Heinonen, J. / Miettola, E. / Ryynänen, O. / Koskela, T. | 2016
A393
Adjusting Variance Parameters to Incorporate Uncertainty into Health Economics Models Following Treatment Switching
Ray, J. / Bennett, I. / Paracha, N. | 2016
A393
The Added Value of Real-World Evidence to Connect Disconnected Networks for Network Meta-Analysis: A Case Study in Rheumatoid Arthritis
Jenkins, D. / Martina, R. / Dequen, P. / Bujkiewicz, S. / Abrams, K. | 2016
A393
Extracting Dosage Per Day From Free-Text Medication Prescriptions
Törnblom, M. / Bergman, G. / Jørgensen, L. / Fackle-Fornius, E. / Rosenlund, M. | 2016
A393
Identifying Higher-Value Subpopulations For Treatment In Heterogenous Rare Diseases: An Example Study of Early Responders to Teduglutide for Short Bowel Syndrome
Chen, K. / Xie, J. / Tang, C. / Zhao, J. / Olivier, C. / Jeppesen, P. / Signorovitch, J. | 2016
A393
Comparison of Bayesian Network Meta-Analyses in a Winbugs and SAS Framework
Le Moine, J. / Abeysinghe, S. | 2016
A394
Network Meta-Analysis Across Longitudinal Time Points: A Comparison of Available Methods
Tallarita, M. / de Iorio, M. / Baio, G. / Karabis, A. | 2016
A394
The Use of ‘Off The Shelf’ Informative Prior Distributions In Random Effect Network Meta-Analysis Models
Batson, S. / Abrams, K. / Sutton, A. | 2016
A394
Is Early Initiation of Biologic Treatment more Effective than a Step up Treatment Approach for New Onset Juvenile Idiopathic Arthritis?-- using a Causal Inference Approach to Achieve a Double Robust Estimate
Huang, B. / Morgan, E. / Chen, C. / Adams, M. / Sivaganisan, S. / Brunner, H. / Guo, J. / Seid, M. | 2016
A394
A Systematic Literature Review on the Efficacy-Effectiveness Gap: Comparison of Randomized Controlled Trials and Observational Studies of Glucose-Lowering Drugs
Ankarfeldt, M. / Adalsteinsson, E. / Groenwold, R. / Ali, S. / Klungel, O. | 2016
A394
Recreational Use of Phosphodiesterase 5 Inhibitors and Its Associated Factors Among Undergraduate Male Students In An Ethiopian University: A Cross-Sectional Study
Gebreyohannes, E. / Bhagavathula, A. / Tefera, Y. / Belachew, S. | 2016
A394
Adjustment Of OS In Crystal For Post-Study Anti-Cancer Therapies
Stapelkamp, C. / Byrne, B. / van Hout, B. | 2016
A395
How to Maximise the Value and Payers’ Acceptance of Single Arm Trial Data in Oncology?
Hoyle, C. / Wright, J. / Ede, J. / van Engen, A. / Ryan, J. | 2016
A395
Adapting to the Challenge: How are Innovative Study Designs Being used in Rare Diseases?
Berry, L. / Eddowes, L. | 2016
A395
Validity and Reliability of Three New Instruments for Parents and Children Assessing Nutrition and Physical Activity Behaviors, Environment and Knowledge and Health in Childhood and Adolescence in Greece During the Economic Recession: Data from the National Action Plan for Public Health (MIS301205)
Carayanni, V. / Vlachopapadopoulou, E. / Psaltopoulou, T. / Koutsouki, D. / Bogdanis, G. / Karachaliou, F. / Manios, Y. / Kapsali, A. / Papadopoulou, A. / Hatzakis, A. | 2016
A395
Making Sense of Clinical Data Reported in Secondary Conditions: The Epidemiology and Clinical Burden of Hyperglycaemia
Cadwell, K. / Pooley, N. / Olariu, E. / Jones, G. / Papageorgakopoulou, C. / Fox, D. | 2016
A395
Important Methodological Considerations and Strategies for Resolution for Multinational Retrospective Chart Review Studies
Bassel, M. | 2016
A396
Making Pragmatic Trials Work
Zuidgeest, M. / Stolk, P. / Oude Rengerink, K. / Goetz, I. / Welsing, P. / Grobbee, D. | 2016
A396
Quasi-Experimental Methods For Real World Data
Menke, J. | 2016
A396
Rationale And Design Of A Multi-Center Survey To Evaluate Productivity Losses And Indirect Costs After Cardiovascular Events In Europe
Gerlier, L. / Sidelnikov, E. / Kutikova, L. / Lamotte, M. / Annemans, L. | 2016
A396
When Is The Use Of A Systematic Literature Review Appropriate? A Comparison Of Systematic, Rapid, And Scoping Reviews And Their Application To The Hta Process
Pooley, N. / Olariu, E. / Floyd, D. | 2016
A396
Generating Real World Evidence: Guidance On The Design And Conduct Of Retrospective Chart Review Studies
Korol, E. / Osenenko, K. / Kayaniyil, S. / McMullen, S. | 2016
A396
The Case For Bayesian Methods In Benefit-Risk Assessment: Overview And Future Directions
Jemiai, Y. / Costa, M. / DiCasoli, C. / Pap, A. / He, W. / Zhao, Y. / Crane, M. | 2016
A397
Comparison Between Cancer Drugs Assessment In Portugal And United Kingdom
Carmo, S. / Ramos, R. / Crespo, N. | 2016
A397
Multi-Criteria Decision Analysis From The Cost-Effectiveness Perspective: Is Mcda A Coherent Way To Allocate Healthcare Resources?
O'Mahony, J. | 2016
A397
Methods For The Design And Conduct Of Medical Record Reviews In Oncology
Wilke, T. / Baeten, S. / Solem, C. / Penrod, J. / Verleger, K. / Lees, M. / Manley Daumont, M. | 2016
A397
Health Economics Analysis Plans: Where Are We Now?
Thorn, J. / Ridyard, C. / Hughes, D. / Wordsworth, S. / Mihaylova, B. / Noble, S. / Hollingworth, W. | 2016
A397
Application Of Quality Indicators To Enable Economic Evaluation Of Quality Improvements – A Bayesian Decision Theoretical And Value Of Information Analytical Framework
Vestergaard, A. / Holger Ehlers, L. | 2016
A397
Innovative Approach To Keeping Evidence Current And Guidelines Living
Lewis, S. / Newton, M. | 2016
A398
Interactive Health Economic Models Configured With Google Analytics. Data And Metrics Applicable For A Healthcare Research
Topachevskyi, O. / Siabro, V. / Volovyk, A. | 2016
A398
Guidance On Selecting Appropriate Methods When Considering Adjusting Overall Survival For Treatment Switch In Oncology Studies
Watkins, C. / Latimer, N. / Wang, J. / Wright, E. | 2016
A398
Using Evidence Reviews To Develop Focused Systematic Review Questions
Upton, CM / Chadda, S / Chapman, R / Curry, A | 2016
A398
A Conceptual Approach For Including Productivity Losses In Health Economic Evaluations From A Societal Viewpoint
Müller, M. / Hofmann, S. | 2016
A398
A Patient Level Simulation Model
Gharibnaseri, Z. / Davari, M. / Cheraghali, A. / Eshghi, P. / Ravanbod, R. / Spendar, R. | 2016
A398
Systematic Review Toolbox
Marshall, C. / Sutton, A. | 2016
A399
Methods For Analyzing Patient-Reported Outcomes In Oncology Trials
Williams, P. / Fofana, F. / de la Loge, C. / Arnould, B. | 2016
A399
Design And Operational Considerations For Hybrid Retrospective-Prospective Studies
Page, M. / Walke, H. | 2016
A399
Utilisation Of Survival Outcomes Data To Forecast Economic Impact Of Pricing And Market Access Scenarios In A Multi-Indication Patient Flow Models
Sogokon, P. / Hunt, M. / Kjeldgaard-Pedersen, J. / Furneri, G. / Chalmers, M. | 2016
A399
Value And Cost Conundrum In Advanced Oncology: Integration Of Value Frameworks Into Cost-Effectiveness Analyes
Ambavane, A. / Benedict, A. / Lanitis, T. / Kongnakorn, T. | 2016
A399
A Secure Smartphone Application For Clinical Research On Wound Healing: Nurstrial
Allaert, F. | 2016
A399
How Assessment Methods May Affect The Efficiency Of Appraisal Process: A Critical Review
Giorgia Tedesco, G. / Francesco Faggiano, F. / Andellini, M. / Leo, E. / Losito, G. / Pietro Derrico, P. / Matteo Ritrovato, M. | 2016
A400
Association Between Exposure To Anticholinergic And Sedative Drugs And Healthcare Costs In Elderly Patients With Cognitive Complaint
Gervais, F. / Dauphinot, V. / Krolak-Salmon, P. / Mouchoux, C. | 2016
A400
The Public Health Perspective Of An Investigational Herpes Zoster Vaccine In The United Kingdom (Uk)
van Oorschot, D. / Hunjan, M. / Varghese, L. / Canavan, C. / Curran, D. | 2016
A400
Effect Of A Multifactorial, Interdisciplinary Intervention On Falls And Fall Rate Of The Older People In The Community
Lee, S. / Kim, H. | 2016
A400
Determination Of Clinical And Cost-Effectiveness Of Various Methods Of Predicting Preterm Birth In Women With High Risk
Tuletova, A. / Dochshanova, A. | 2016
A400
The Public Health Impact Of A New Herpes Zoster Vaccine To The German Population
van Oorschot, DA / Anastassopoulou, A / Schlegel, K / Varghese, L / von Krempelhuber, A / Curran, D | 2016
A401
Availability And Costs Of Pediatric Formulations In India : A Case Study
Tayal, H. / Roy, V. | 2016
A401
Budget Impact Of Ulipristal Acetate 5mg In Pre-Operative Treatment Of Uterine Fibroids: An Analysis Based On Public Data On Hospital Stays In France
Trancart, M. / Lehmann, M. / Lafuma, A. | 2016
A401
Economic Evaluation Of Rfsh And Hp-Hmg For Infertility Treatment In Brazil
Souza, P. / Simões, A. / Zanini, F. / Sato, C. | 2016
A401
The Prevalence Of Sexual Dysfunctions Among Hungarian Men
Palancsa, M. / Damásdi, M. / Gitta, S. / Tardi, P. / Járomi, M. / Ács, P. / Boncz, I. / Hock, M. | 2016
A401
Budget-Impact Analysis (Bia) Of The Introduction Of 52mg Levonorgestrel-Releasing Intrauterine System (Lng-Ius) As A Contraceptive Method Option In The Brazilian Public Healthcare System (Sus) To Avoid Unintended Pregnancy (Up) In 15 To 19 Year-Old Adolescents
Ramos, N. / Honda, A. / Sakagute, M. / Nakada, C. / Tobaruella, F. | 2016
A401
Iron Deficiency Anemia In Pregnant Women In France: A Prospective Cohort Study
Clavel, T. / Zkik, A. / Berdeaux, G. / Auges, M. / Sanchez, C. / Harvey, T. | 2016
A402
Infertility Treatment Of Women Over Age 35 In Brazil: An Economic Evaluation Of Recombinant VS. Urinary Gonadotropins
Souza, P. / Simões, A. / Zanini, F. / Sato, C. | 2016
A402
Analysis Of Real Data For Treatment Of Nausea And Vomiting Of Pregnancy (Nvp) In Ukraine
Maksymovych, N. / Zalis'ka, O. / Brezden, O. | 2016
A402
Cost-Effectiveness Of Recombinant Human Follicle Stimulating Hormone Biosimilars In Portugal
Silverio, N / Botica, F / Batista, AR | 2016
A402
Evaluating The Economic Impact Of Potentially Inappropriate Prescribing In Older People In Ireland Using A Markov Modelling Approach
Moriarty, F. / Bennett, K. / Cahir, C. / Fahey, T. | 2016
A402
Cost-Effectiveness Analysis Of 52 Mg Levonorgestrel-Releasing Intrauterine System (Lng-Ius) Versus Short-Acting Hormonal Contraceptives In Avoiding Unintended Pregnancy (Up) In 15 To 19 Year-Old Adolescents Under The Brazilian Public Healthcare System (Sus)
Honda, A. / Ramos, N. / Sakagute, M. / Nakada, C. / Tobaruella, F. | 2016
A402
Cost Implications Of Inappropriate Prescribing Of Anti-Malarial Therapy For Treatment Of Undifferentiated Febrile Illness Among Elderly
Menon, V. / Ramesh, M. / Pereira, P. / CR, V. / Undela, K. | 2016
A403
Cost Minimisation Analysis Of Follitropin Delta Versus Follitropin Alfa In Assisted Reproductive Technologies (Ivf/Icsi) In The United Kingdom
Sivignon, M. / Palencia, R. / Roze, S. | 2016
A403
The Impact On Societal Burden Of Changed Uptake Of Hormonal Treatments
Widen, J / Hallberg, S / Bobula, J / Moffatt, M / Borgstrom, F | 2016
A403
Cost-Effectiveness Analysis Of Laparoscopic Surgery For Presumed Leiomyomas
Lin, Y. / Lang, H. / Tsai, Y. | 2016
A403
Cost‐Utility Analysis Of Ulipristal Acetate (5 Mg) For Long-Term Treatment Of Moderate To Severe Symptoms Of Uterine Fibroids In Portugal
Paquete, A. / Lehmann, M. / Silva, D. / Pinto, C. | 2016
A403
Clinical And Economic Analysis Of Two Surfactants For The Prevention And Treatment Of Respiratory Distress Syndrome
Krasnova, L. / Vorobiev, P. / Tyurina, I. | 2016
A403
Vaginal Birth After Caesarean Versus Elective Repeat Caesarean Delivery In Four European Countries: A Cost-Utility Analysis
Fobelets, M. / Beeckman, K. / Faron, G. / Putman, K. | 2016
A404
Comparison Between Eq-5d And Hui In Japanese Population Norms
Noto, S. / Izumi, R. / Moriwaki, K. / Shiroiwa, T. / Igarashi, A. / Fukuda, T. / Ikeda, S. / Saito, S. / Shimozuma, K. / Ishida, H. | 2016
A404
A Review Of Patient-Reported Outcome Measures To Assess Infertility-Related Quality Of Life
Kitchen, H. / Aldhouse, N. / Trigg, A. / Palencia, R. / Mitchell, S. | 2016
A404
Willingness To Pay For Primary Dysmenorrhea Health States
Ruzsa, G / Gulacsi, L / Brodszky, V / Péntek, M / Gradvohl, E / Rencz, F | 2016
A404
Self-Efficacy And Health Behaviors Impact Quality Of Life Of Elderly Along Eastern Sea Coast Of Thailand 2015
Auamnoy, T. / Onnim, P. / Suriyong, P. / Dechrat, P. | 2016
A404
Rescaling The Overall Score In The Cervantes Short-Form Scale For Measuring Health-Related Quality Of Life In Menopausal Women Sexually Inactive
Coronado, P. / Sánchez-Borrego, R. / Ruiz, M. / Rejas, J. / Collaborative Group, C. | 2016
A404
Translation And Validation Of Condition-Specific Quality Of Life Pfdi-20 And Pfiq-7 Questionnaires For Women With Pelvic Floor Dysfunction In The Norwegian Context
Teig, C. / Bond, M. / Cvancarova, M. / Engh, M. / Kjøllesdal, M. / Øresland, T. / Saga, S. / Martini, A. | 2016
A405
Assessing Real Consumption of Medications for Fertility Treatments in Ukraine
Piniazhko, O. / Zalis'ka, O. / Vons, B. / Pyrohova, V. / Malachynska, M. / Veresnyuk, N. | 2016
A405
Irrational Use of Antibiotics in Turkey
Malhan, S. / Numanoglu Tekin, R. / Oksuz, E. | 2016
A405
Analysis of Antibiotics’ Use in the Treatment of Tonsillopharyngitis in Children Population of Nis District
Krajnovic, D. / Arsic, J. / Milijic, S. / Milosević Georgiev, A. | 2016
A405
Use, Belief, and Risk Awerness to Medication Among Pregnant Women Attending Antenatal Care Unit at University of Gondar Teaching Hospital, Northwestethiopia: Crosssectional Study
Tefera, Y. / Admasu, S. | 2016
A405
Kangaroo Mother Care- A Cost Effective and an Alternate Method to Manage Hypothermia in Low Birth Weight Babies for Better Clinical Outcome
Kanodia, P. / Bora, R. / Gupta, A. | 2016
A406
Long Term Outcome of Couples Undertaking their First IVF/ICSI Attempt: A French Study
Parneix, I. / Arvis, P. / Paillet, S. / Longin, J. / Lehert, P. / Avril, C. / Lesourd, F. | 2016
A406
Prevalence of Potentially Inappropriate Prescribing in Central Nervous System and Psychotropic Drugs for the Korean Elderly: A Cross-Sectional Study Using the National Health Insurance Claims Database
Cho, H. / Choi, J. / Kang, H. | 2016
A406
Cyproterone/Ethinylestradiol Use and Indications in the Netherlands
Bezemer, I. / Smits, L. / Penning-van Beest, F. / Asiimwe, A. / Herings, R. | 2016
A406
Assessment of the Costs of Overall Children Vaccination with Antirotavirus Vaccine in Ukraine
Nemchenko, A. / Podgaina, M. / Balynska, M. | 2016
A406
The Chickenpox Complications and Financial Burden in Healthy Children and with Underlying a Comorbidity During the Pre Vaccine and Post Vaccine Era in a University Hospital
Büyükcam, A. / Çelik, M. / Ceyhan, M. / Kara, A. | 2016
A406
Cyproterone/Ethinylestradiol and Concomitant Use of other Hormonal Contraceptives in the Netherlands
Bezemer, I. / Smits, L. / Penning-van Beest, F. / Asiimwe, A. / Herings, R. | 2016
A407
Comparative Effectiveness of Carbapenems Versus Alternative Antibiotics for the Treatment of Bacteraemia Due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Empirical Therapy: Multicenter Cohort Study
Lee, N. / Son, S. / Park, J. / Park, D. | 2016
A407
Zinforo (Ceftaroline Fosamil) Versus other Empiric Antibiotics for Moderate-to-Severe Community Acquired Pneumonia (CAP) In Adults: a Network Meta-Analysis
Rao, N / Gibson, E / Lawson, RW / Goodall, JJ | 2016
A407
Comorbidities in HIV-1: A Literature Review of the Associations Between Patient- and Disease-Related Factors and Non-Aids Related Comorbidities (NARCS)
Bunting, C. / Eddowes, L. / Buchanan-Hughes, A. / Steeves, S. / Perard, R. / Hay, P. | 2016
A407
Translation of the UK Paediatric Influenza Primary School Vaccination Programme to 13 European Countries Using a Dynamic Transmission Model
Gerlier, L. / Hackett, J. / Lawson, R. / Dos Santos Mendes, S. / Eichner, M. | 2016
A407
Comparative Effectiveness of Carbapenems Versus Alternative Antibiotics for the Treatment of Bacteraemia Due to Enterobacteriaceae Producing Extended-Spectrum β-Lactamase in Definitive Therapy: A Systematic Review and Meta-Analysis
Son, S. / Lee, N. / Park, J. / Park, D. | 2016
A408
Therapeutic Indication of Lyophilized Hydrocortisone to the Treatment of Trichinosis with Neurological and / or Myocardial Involvement
Zanghelini, F. / Rego, M. / Oliveira, M. / Andrade, C. / Pereira, M. / Nunes, T. / Galdino-Pitta, M. / Viana, D. / Cardoso, P. / Pitta, M. | 2016
A408
Why is the Herd Protection Level Higher in the UK than in Belgium after the Introduction of the Rotavirus Vaccine?
Standaert, B. / Schecroun, N. / Lorenc, S. | 2016
A408
Zinforo (Ceftaroline Fosamil) Versus other Empiric Initial IV Antibiotics for Complicated Skin and Soft Tissue Infections (CSSTI): A Network Meta-Analysis
Rao, N. / Gibson, E. / Lawson, R. / Goodall, J. | 2016
A408
Susceptibility Pattern of Pseudomonas Aeruginosa Isolates to Carbapenem Antibiotics
Zubair, M. / Hussain, T. | 2016
A408
Evaluation of the Number Needed to Vaccinate (NNV) with Gardasil9 in order to Avert 1 Case of Human Papillomavirus (HPV)-Related Anogenital Disease in France
Uhart, M. / Largeron, N. / Drury, R. / Soubeyrand, B. | 2016
A408
Hepatitis C – Real World Effectiveness of HCV Treatment in Poland
Plisko, R. / Wladysiuk, M. / Miazga, P. / Bebrysz, M. | 2016
A409
Budget Impact Analysis Of Ceftolozane/Tazobactam (Zerbaxa) For The Treatment Of Complicated Intra-Abdominal Infections And Complicated Urinary Tract Infections In The Italian Setting
Barbieri, M / Crocchiolo, D / Veneziano, MA | 2016
A409
Burden of Medically Attended Acute Gastroenteritis in England: A Cohort Study in CPRD
Ferreira, G. / Lopman, B. / Tam, C. / Harris, J. / Bollaerts, K. / Cattaert, T. / Riera, M. / Vestraeten, T. | 2016
A409
Prediction of the Morbidity with Bacterial Purulent Meningitis of Various Origin with Consideration of the Existing Vaccine Prevention Procedures
Ryazhenov, V. / Gorokhova, S. | 2016
A409
Managing Healthcare Resources: Estimated Budget Impact On The National Health Service (England) Of Introduction Of Antimicrobial Sutures
Edmiston, C. / Holy, C. / Leaper, D. | 2016
A409
Findings of a Literature Review in Support of a Patient Count Model (PCM) for Hepatitis C Virus (HCV) in the EU5
Gueron, B. / Nalpas, C. / Maiese, B. / Cadarette, S. / Campbell, D. / Arvin-berod, C. / Duchesne, I. | 2016
A410
Budget Impact Analysis Of The Introduction Of Darunavir 800 Mg Qd For The 2nd Line Treatment Of Hiv-Infected Treatment-Experienced Adults On The Brazilian National Hiv Program
Ferreira, K. / Neves, J. / Asano, E. / Magno, L. / Loureiro, R. | 2016
A410
Cost Analysis Of Comorbities: Evidence From A Hiv+ Patients Cohort
Foglia, E / Ferrario, L / Garagiola, E / Rizzardini, G / Meraviglia, P / Atzori, C / Croce, D | 2016
A410
Budget Impact Analysis Of Including A Pentavalent (Hib-Hbv-Dtp) Vaccine In The National Childhood Immunization Schedule Of Iran
Teimouri, F. / Nikfar, S. / Kebriaeezadeh, A. | 2016
A410
Budget Impact Associated With The Implementation Of A Dtpa-Ipv-Hepb/Hib Hexa Vaccination Program In Slovenia
Demarteau, N. / Geets, R. / Plevnik Kapun, A. | 2016
A410
Health Care Costs, Lenght Of Stay And Mortality Of Carbapenem Resistance Gram-Negative Bacteremia
Aykac, K. / Tanır Basaranoglu, S. / Ozsurekci, Y. / Ceyhan, M. | 2016
A410
Cost Analysis Of Raltegravir Versus Atazanavir/R Or Darunavir/R For Treatment-Naive Adults With Hiv-1 Infection In Spain
Davis, A. / Brogan, A. / Goodwin, B. / Nocea, G. / Lozano, V. | 2016
A411
Direct Cost Of Hiv/Aids In Turkey
Tatar, M. / Kockaya, G. / Ozelgun, B. / Zengin Elbir, T. / Senturk, A. / Tuna, E. / Unal, S. / Tumer, A. / Inkaya, C. | 2016
A411
Burden Of Comorbidities In Hcv And Hiv/Hcv Patients. Real world evidence from italian administrative databases
Perrone, V. / Sangiorgi, D. / Crovato, E. / Buda, S. / Degli Esposti, L. | 2016
A411
Determination Of The Vaccine-Preventable Diseases Burden In Turkey In Terms Of Various Vaccination Policies
Ceyhan, M. / Bayhan, C. / Ozsurekci, Y. / Malhan, S. / Numanoglu Tekin, R. / Mcintosh, D. | 2016
A411
Indirect Cost Of Hiv/Aids: Results Of A Survey From A Turkish Research Center
Tatar, M. / Kockaya, G. / Ozelgun, B. / Zengin Elbir, T. / Senturk, A. / Tuna, E. / Unal, S. / Tumer, A. / Inkaya, C. | 2016
A411
Health Resources Use In Patients With Human Immunodeficiency Virus (Hiv) Infection. Real world evidence from italian administrative databases
Perrone, V. / Sangiorgi, D. / Crovato, E. / Buda, S. / Degli Esposti, L. | 2016
A411
Complications And Health Care Costs Of Influenza In Germany: A Retrospective Claims Data Analysis
Scholz, S. / Damm, O. / Ultsch, B. / Schneider, U. / Remschmidt, C. / Weidemann, F. / Wichmann, O. / Greiner, W. | 2016
A412
Evaluation Of The Clinical Characteristics And Economic Burden Of United States Veteran Patients Diagnosed With The Hepatitis C Virus
Wang, L. / Li, L. / Zhou, X. / Pandya, S. / Baser, O. | 2016
A412
Cost Assessment Of Antibiotics Use In A Hospital In The Dominican Republic
Mouly, M. / Puello Guerrero, A. / Dumartin, C. / Silva, M. / Aulois-Griot, M. | 2016
A412
Patient Characteristics And Outcomes Of Hospitalization For Influenza Infection In Hong Kong
Chan, Y. / Lee, N. / You, J. | 2016
A412
Clinical And Econimic Burden Of Community-Onset Complicated Skin And Skin Structure Infection (Csssi) In Korea
Lee, M. / Kim, Y. / Cho, Y. | 2016
A412
What Is The Hospital Economic Burden Of Hiv In France? Results from an analysis of the national french medical information system database
Yazdanpanah, Y. / Bonnet, F. / de Léotoing, L. / Finkielsztejn, L. / Chaize, G. / Vainchtock, A. / Nachbaur, G. / Aubin, C. | 2016
A413
Clinical And Economic Outcomes Of Patients Hospitalized For Herpes Zoster In Hong Kong
Yu, W. / Chan, P. / You, J. | 2016
A413
The Public Health And Economic Impact Of Gender Neutral Quadrivalent Human Papillomavirus Vaccination Program In Brazil
Coutinho, M. / Serra, F. / Monsanto, H. / Kulkarni, A. / Pavelyev, A. | 2016
A413
Assessing The Consequences Of Sustained Off-Therapy Hbsag Loss In Health Economic Models Of Chronic Hepatitis B; A Systematic Literature Review
Hashim, M. / Cerri, K. / Sbarigia, U. / Heeg, B. | 2016
A413
Cost-Effectiveness Analysis Of Highly Innovative Treatments For Hepatitis C: The Case Of Ledipasvir/Sofosbuvir In A Greek Healthcare Setting
Athanasakis, K / Boubouchairopoulou, N / Kyriopoulos, I / Tsoulas, C / Tzanakis, B / Kyriopoulos, J | 2016
A413
Determining The Clinical Practice And Resource Use Associated To The Diagnosis And Treatment Of Clostridium Difficile Infection In Mexico
Pérez Bolde-Villarreal, C. / Pastor-Martínez, V. / reyes-Lopez, A. / Jimenez-Juarez, R. | 2016
A413
Universal Mass Vaccination With Phid-Cv Is Cost-Effective In Croatia
Bencina, G. / Olbrecht, J. | 2016
A414
Cost Of Dengue And Cost-Effectiveness Of The Dengue Vaccine In Panama
Garcia, L. / Cerezo, L. / Blas, A. / Alvarez, S. / Quiroz, N. / Caicedo Navas, A. / Lopez, J. / Vandeputte, C. | 2016
A414
Cost-Effective Analysis Of The Dengue Vaccine In Costa Rica
Xirinachs, Y | 2016
A414
A Systematic Review Of The Cost-Effectiveness Of Quadrivalent Influenza Vaccine
van Maanen, B. / Postma, M. / de Boer, P. | 2016
A414
Cost-Effectiveness Evaluation Of Phid-Cv Versus Pcv-13 In Poland
Wepsięć, K. / Stryjewska, I. / Mrozek-Gasiorowska, M. / Olbrecht, J. | 2016
A414
Cost-Effectiveness Of The 13-Valent Pneumococcal Conjugate Vaccine In Adults In Portugal
Alarcão, J. / Fiorentino, F. / Gouveia, M. / Jesus, G. / Costa, J. / Borges, M. | 2016
A415
Cost-Effectiveness Analysis Of Sofosbuvir For Genotype 2 Hepatitis C In Greece
Athanasakis, K. / Boubouchairopoulou, N. / Kyriopoulos, I. / Tsoulas, C. / Tzanakis, B. / Kyriopoulos, J. | 2016
A415
Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir In Treatment Of Chronic Hepatitis C In The Russian Federation
Yagudina, R. / Kulikov, A. / Babiy, V. | 2016
A415
Cost-Effectiveness Of Prevenar 13 In Children In Portugal
Fiorentino, F. / Gouveia, M. / Jesus, G. / Costa, J. / Borges, M. | 2016
A415
Cost Effectiveness Analysis Of Different Health Policies Based On The Second Generation Daa-Ifn Free Regimens In An Italian Population
Ruggeri, M. / Romano, F. | 2016
A415
Cost-Effectiveness Analysis Of Daclatasvir With Asunaprevir Vs Paritaprevir/Ritonavir/Ombitasvir With Dasabuvir In Treatment Of Chronic Hepatitis C In The Russian Federation
Yagudina, R / Kulikov, A / Babiy, VV | 2016
A415
Cost-Effectiveness Of Grazoprevir / Elbasvir In Patients With Chronic Hepatitis C Virus
Mattingly, T. / Slejko, J. / Mullins, C. | 2016
A416
Beyond Cervical Cancer: The Cost-Effectiveness Of Hpv Vaccination In The Netherlands
Setiawan, D / Cao, Q / Westra, TA / Postma, MJ | 2016
A416
Economic Evaluation Of Yellow Fever Routine Vaccination In Colombia
Hoestlandt, C. / Broban, A. / Houillon, G. / Caicedo, A. / Martinez, J. / Kieffer, A. | 2016
A416
Cost-Effectiveness Of Ombitasvir/Paritaprevir/Ritonavir With Or Without Dasabuvir For The Treatment Of Chronic Hepatitis C Patients Infected With Genotype 1 Or 4 In France
Sroczynski, G. / Conrads-Frank, A. / Mühlberger, N. / Kühne, F. / Jeanblanc, G. / Samp, J. / Durand-Zaleski, I. / Siebert, U. | 2016
A416
Cost Of Dengue Illness And Cost-Effectiveness Of The Cdy-Tdv Dengue Vaccine In Ecuador
Lucio-Romero, R. / Henriquez-Trujillo, A. / Bermudez-Gallegos, K. / Tello-Ponce, B. / Caicedo Navas, A. / Vandeputte, C. | 2016
A416
Inclusion Of Costs And Effects Related To Toxicity/Safety In Cost -Effectiveness Analysis; An Illustration For Influenza Vaccines
Fens, T. / de Boer, P. / Postma, M. | 2016
A417
Systematic Review Of Studies Estimating The Cost-Effectiveness Of Hiv Pre-Exposure Prophylaxis (Prep) In Men Who Have Sex With Men (Msm)
Damm, O. / Scholz, S. / Greiner, W. | 2016
A417
Determening The Optimal Price For New Non-Nucleoside Reverse Transcritase Inhbitor Using Early Economic Modeling
Musina, N / Pogorelova, E / Savilova, A / Korzinov, O | 2016
A417
Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1a Hcv In Greece
Mylonas, C. / Kourlaba, G. / Vernadaki, A. / Kakouros, M. / Maniadakis, N. | 2016
A417
Economic Evaluation Of Abbvie’s Regimen (Viekirax/Exviera) For Patients With Genotype 1b Hcv In Greece
Mylonas, C. / Kourlaba, G. / Vernadaki, A. / Kakouros, M. / Maniadakis, N. | 2016
A417
The Cost Of Treating Mucormycosis With Isavuconazole Compared With Liposomal Amphotericin B Followed By Posaconazole In The United Kingdom: Economic Evaluation Of The Phase Iii Vital Study And Fungiscope Matched Case-Control Analysis
Kuessner, D. / Bagshaw, E. / Blackney, M. / Cornely, O. / Heimann, S. / Posthumus, J. | 2016
A417
Cost Minimization Analysis Of Tedizolid For The Treatment Of Acute Bacterial Skin And Skin Sub-Structure Infections (Absssi) In Greece
Insinga, R. / Dalakaki, E. / Retsa, M. / Karokis, A. / Sarpong, E. | 2016
A418
Health State Utility Values (Hsuvs) Measured By The Euroqol 5-Dimensions (Eq-5d) Questionnaire In People Living With Hiv (Plhiv): A Systematic Literature Review (Slr) Using Rapid Review Methodology
Buchanan-Hughes, A. / Eddowes, L. / Ma, Q. / Perard, R. / Hay, P. | 2016
A418
Dengue Negatively Affects Gdp And Federal Revenues In Endemic Areas Of Mexico
Samaniego, R. / Aburto, C. | 2016
A418
Health State Utilities Associated with Post-Surgical Staphylococcus Aureus Infection
Matza, L. / Kim, K. / Yu, H. / Belden, K. / Chen, A. / Kurd, M. / Lee, B. / Webb, J. | 2016
A418
Effect Of Sociodemographic Determinants And Socio-Economic Status On Poliomyelitis Immunization Among Under-Five Children In Pakistan
Iqbal, MS / Iqbal, MZ / Bahari, MB | 2016
A418
Economic Evaluation Of Abbvie’s Regimen (Viekirax) For Patients With Genotype 4 Hcv In Greece
Mylonas, C. / Kourlaba, G. / Vernadaki, A. / Kakouros, M. / Maniadakis, N. | 2016
A419
German Travelers' Preferencences For Vaccines Against Travel-Related Illnesses
Poulos, C / Curran, D / Anastassopoulou, A / De Moerlooze, L | 2016
A419
Work and Income Loss Consideration Among Patients With Herpes Zoster When Completing A Quality Of Life Questionnaire
Johnson, K. / Brenneman, S. / Newransky, C. / Sheffler-Collins, S. / Becker, L. / Belland, A. / Acosta, C. | 2016
A419
A Systematic Review Of Utilitiy Weights For Influenza And Influenza-Like Illness
Damm, O. / Scholz, S. / Ultsch, B. / Weidemann, F. / Remschmidt, C. / Wichmann, O. / Greiner, W. | 2016
A419
Health State Utility Values (Hsuvs) Measured Using The Euroqol 5-Dimensions (Eq-5d) Questionnaire In Adults With Chronic Hepatitis C (Chc): A Systematic Literature Review (Slr)
Buchanan-Hughes, A. / Hanman, K. / Langford, B. / Eddowes, L. | 2016
A419
What Motivates Mothers To Pay For A Vaccine Against Children’s Diarrhea? Preferences for vaccines against children’s diarrheal illness among mothers in poland and hungary
Poulos, C. / Standaert, B. / Sloesen, B. / Hauber, A. | 2016
A420
Herpes Zoster And Postherpetic Neuralgia: Quality Of Life And Healthcare Utilization, A German Study
Anastassopoulou, A. / Curran, D. / Schmidt‐Ott, R. / Schutter, U. / Simon, J. / Poulsen Nautrup, B. / Matthews, S. | 2016
A420
Psychometric Validation Of Four Patient-Reported Outcome Instruments In A Diverse Sample Of Adults With Chronic Hepatitis C Virus Infection Treated With Simeprevir And Sofosbuvir
Trigg, A. / Kitchen, H. / Willgoss, T. / Ho, K. / Pierson, R. / Scott, J. | 2016
A420
Impaired Quality Of Life After Chikungunya Virus Infection: A 12-Months Follow-Up Study Of Its Chronic Inflammatory Rheumatism In La Virginia, Risaralda, Colombia
Rodriguez-Morales, A. / Restrepo-Posada, V. / Acevedo-Escalante, N. / Rodríguez-Muñoz, E. / Valencia-Marín, M. / Castrillón-Spitia, J. / Londoño, J. / Bedoya-Rendón, H. / Jd, C. r. / Cardona-Ospina, J. | 2016
A420
Psychometric Evaluation Of The Revised Hiv Treatment Satisfaction Questionnaire (Hivtsq)
Romaine, J. / Murray, M. / Bradley, C. | 2016
A420
Analysis Of Influenza Vaccination Effectiveness In General Practitioner
Lehocka, L. / Masarykova, L. / Olearova, A. / Koscova, D. | 2016
A420
Soft Modelling Of Health-Related Quality Of Life Specific To Hiv In Relation To Anxiety, Depression, Personality Traits And Precariousness
Aboromman, M. / Lalanne, C. / Dimi, S. / Carrieri, P. / Reeder, A. / Zucman, D. / Chassany, O. / Duracinsky, M. | 2016
A421
Impact of Dosing Schedule on the Success of A Vaccination Programme in an Elderly Population
Matthews, I. / Dawson, H. / Préaud, E. / Lu, X. / Harrison, J. / Lee, A. | 2016
A421
Utilisation of Antiretrovirals in the Slovak Republic - A 10-Year Retrospective Study
Olearova, A. / Navratil, M. / Lehocka, L. / Masarykova, L. | 2016
A421
Dispensing Patterns of Vaccines by Pharmacies in South Africa
Truter, I. / Lamprecht, J. | 2016
A421
Utilisation and Dosage Patterns of Intravenous Echinocandins for Treatment of Invasive Fungal Infections Within Hospitals in England
Ahir, H. / McCann, E. / Robertson, S. / Patel, S. / Yu, E. / Tham, R. | 2016
A421
Seasonal Variations of Outpatient Antibiotic use in Austria
Hinteregger, M. / Janzek-Hawlat, S. / Reichardt, B. | 2016
A422
Length of Stay, Costs and Mortality Attributable to Clostridium Difficile Infections in 13 Belgian Hospitals
Pirson, M. / Poirrier, J. / Joubert, S. | 2016
A422
Direct Costs Associated to Meningococcal Disease and Related Sequelae in Children – Analysis Based on the Brazilian Public Health System Perspective
Salgado, J. / Silva, D. / Lorenzato, F. / Cintra, O. / Saturnino, L. | 2016
A422
General Practitioners Perceptions About Financial and Non-Financial Incentives to Improve Influenza Vaccination Coverage Rates In France
Silva, M. / Perrier, L. / Späth, H. / Paget, J. / Buthion, V. / Mosnier, A. / Cohen, J. / Aulois-Griot, M. | 2016
A422
Value of Expanding Hcv Treatment Capacity in Germany Through Novel, Effective and Shorter Duration Therapies
Sbarigia, U. / Wirth, D. / Van Nuys, K. / Huber, C. / Brookmeyer, R. / Stahmeyer, J. / Krauth, C. | 2016
A422
Estimating the Value of A New Antibiotic: A Novel Approach Using Esbl As A Case Study
Geale, K / Corcoran, K / Virhage, M / Anell, B | 2016
A422
Reducing disparities in u.s. Vaccination through senior centers: A Comparison of three Educational Models for Older African Americans
Prioli, K. / Schafer, J. / Pizzi, L. | 2016
A423
Public Knowledge and Attitudes Towards Zika Virus and its Prevention in Malaysia
Khan, MU / Ahmad, A / Arief, M / Saleem, F / Hassali, MA / Bhagavathula, AS | 2016
A423
The Potential Public Health Impact of Varicella Vaccination in Hungary
Meszner, Z. / Benedek, A. / Kyle, J. / Pillsbury, M. / Wolfson, L. | 2016
A423
The Impact of Regional Cost-Saving Initiatives on the Uptake of Antiretroviral Drugs in London
Ohanjanyan, A. / Mukku, D. / Edathodu, A. / Samuel, J. / Leung, S. | 2016
A423
Sick Leave and Disability Pension in Patients with Chronic Hepatitis C Compared with Matched General Population Comparators: A Nationwide Population-Based Register Study
Büsch, K. / Hansson, F. / Kövamees, J. / Söderholm, J. | 2016
A423
First Results From A Retrospective Study on the Epidemiology of the Hungarian Hiv Infected Population
Kósa, F. / Takács, P. / Tronczynski, K. / Duchesne, I. / Kasza, K. / Merth, G. / Merész, G. / Rózsa, P. / Szlávik, J. | 2016
A424
Health Technology Assessment of the use Vaccines for Prevention Flu
Vorobiev, P. / Dugin, D. / Krasnova, L. | 2016
A424
The Prevalence of Nosocomial Infections in Karaganda (Kazakhstan) During 2011-2015
Kultanova, E. / Lavrinenko, A. / Turmukhambetova, A. | 2016
A424
Economic Burden of Anti-Methicillin-Resistant Staphylococcus Aureus (Mrsa) Therapy in Public Hospitals of Paris (Ap-Hp) and Adequacy with the Defined Daily Doses
Therasse, C. / Fusier, I. / Cordonnier, A. / Vittecoq, D. / Paubel, P. | 2016
A424
Antibiotic Utilisation and Expenditure in Ireland
Clarke, S / Bennett, K / Oza, A / Cunney, R / Barry, M | 2016